Pharma company executives debate drug pricing increases

A person holds pharmaceutical tablets and capsules in illustration picture in LjubljanaThe pharmaceutical industry is typically reluctant to talk about U.S. drug prices, generally the highest in the world due to a combination of market fragmentation and free market policies. AbbVie Inc on Wednesday became the third global drugmaker to publicly promise to cap annual price increases at under 10 percent, following earlier pledges by Allergan Plc and Novo Nordisk A/S . "I do think that the industry is off to a good start in terms of good behavior," Allergan Chief Executive Officer Brent Saunders told investors here this week during J.P. Morgan's annual healthcare conference, the largest industry meeting of the year.

Source: Feed3

Leave a Reply

Your email address will not be published. Required fields are marked *